<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02552069</url>
  </required_header>
  <id_info>
    <org_study_id>SJCR-OR-1505</org_study_id>
    <nct_id>NCT02552069</nct_id>
  </id_info>
  <brief_title>Tritanium® Study in Japan</brief_title>
  <official_title>The Verification Study on the Early Fixation/ Stability of Tritanium Cup</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Japan K.K.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Japan K.K.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate early fixation and stability of the Tritanium cup.
      It is expected that the Tritanium® cup will be equal to or better than conventional
      cementless cups in early fixation/stability and meet the expectations of Japanese surgeons.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in implantation position(angle) of the cup</measure>
    <time_frame>Baseline, intraoperative, 3 months, 6 months and 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Japanese Orthopaedic Association (JOA) score</measure>
    <time_frame>Baseline, 3 months, 6months and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality of Life as assessed by Euro QOL 5 Dimension (EQ-5D)</measure>
    <time_frame>Pre-operation, 3 months, 6months and 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Osteoarthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Avascular Necrosis of the Femoral Head</condition>
  <arm_group>
    <arm_group_label>Tritanium® cup</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Tritanium® cup</intervention_name>
    <arm_group_label>Tritanium® cup</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is a candidate for a primary Total Hip Arthroplasty (THA).

          2. Patient who has diagnosis of secondary osteoarthritis, avascular necrosis and
             rheumatoid arthritis.

          3. Patient whose age is 20 or over.

          4. Patient who signed an Institutional Review Board (IRB)-approved, study specific
             Informed Patient Consent Form.

          5. Patient who is willing and able to comply with postoperative scheduled evaluations.

        Exclusion Criteria:

          1. Patient who has a bacterial infectious disease or has a high risk of a bacterial
             infection.

          2. Patient who requires revision surgery of a previously implanted total hip
             arthroplasty.

          3. Patient who is morbidly obese, defined as having a Body Mass Index (BMI) &gt; 40.

          4. Patient who is or may be pregnant female.

          5. Patient who has neuromuscular or neurosensory deficiency, which limits ability to
             evaluate the safety and efficacy of the device.

          6. Patient with diagnosed systemic disease (i.e. Paget's disease, renal osteodystrophy),
             which limits ability to evaluate the safety and efficacy of the device.

          7. Patient who is immunologically suppressed or receiving chronic steroids, which limits
             ability to evaluate the safety and efficacy of the device.

          8. Patients who is judged ineligible with specific reason by primary doctor.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yasuyuki Inatsugu</last_name>
    <role>Study Director</role>
    <affiliation>Stryker Japan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ysuyuki Inatsugu</last_name>
    <phone>+81-3-6894-8394</phone>
    <email>yasuyuki.inatsugu@stryker.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>RINKU General Medical Center</name>
      <address>
        <city>Izumisano</city>
        <state>Osaka</state>
        <zip>598-8577</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+81-72 - 469 - 3111</phone>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2015</study_first_submitted>
  <study_first_submitted_qc>September 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Femur Head Necrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

